MorphoSys AG (MOR) Surges as Analyst Speculates on Buyout That Could Come at 175% Premium Jul 6, 2022 11:06AM
MorphoSys AG (MOR) Has Positive Read from Biogen's Aducanumab News - RBC Oct 22, 2019 11:47AM